K972790

Substantially Equivalent

THE THERATEST EL-B2GP1 (IGM, IGG, IGA) AND EL-B2GP1SCR

Applicant: Theratest Laboratories, Inc.
Product code: MSV
Advisory panel: Immunology
Date received: 1997-07-28
Decision date: 1997-12-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chicago, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.